Mounjaro® (Tirzepatide) is an innovative dual-action treatment for type 2 diabetes and weight management. It works by uniquely targeting both GIP and GLP-1 receptors, offering superior blood sugar control and significant weight loss. The medication is conveniently administered via a once-weekly subcutaneous injection.